Patents by Inventor Nicole Sawyer

Nicole Sawyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6395499
    Abstract: A human prostaglandin receptor has been identified and DNA encoding the receptor has been isolated, purified, sequenced and expressed in host cells. This DNA encoding the human prostaglandin receptor and host cells expressing the receptor are used to identify modulators of the prostaglandin receptor.
    Type: Grant
    Filed: June 20, 2000
    Date of Patent: May 28, 2002
    Assignee: Merck Frosst Canada & Co.
    Inventors: Mark Abramovitz, Kathleen Metters, Yves Boie, Nicole Sawyer, Deborah M. Slipetz
  • Patent number: 6214972
    Abstract: A novel human DP prostaglandin receptor has been identified and DNA encoding the receptor has been isolated, purified, sequenced and expressed in host cells. This DNA encoding the novel prostaglandin receptor and host cells expressing the receptor are used to identify modulators of the prostaglandin receptor.
    Type: Grant
    Filed: April 28, 1999
    Date of Patent: April 10, 2001
    Assignee: Merck Frosst Canada & Co.
    Inventors: Mark Abramovitz, Yves Boie, Kathleen Metters, Nicole Sawyer, Deborah M. Slipetz
  • Patent number: 5958723
    Abstract: A novel human DP prostaglandin receptor has been identified and DNA encoding the receptor has been isolated, purified, sequenced and expressed in host cells. This DNA encoding the novel prostaglandin receptor and host cells expressing the receptor are used to identify modulators of the prostaglandin receptor.
    Type: Grant
    Filed: March 6, 1997
    Date of Patent: September 28, 1999
    Assignee: Merck Frosst Canada & Co.
    Inventors: Mark Abramovitz, Yves Boie, Kathleen Metters, Nicole Sawyer, Deborah M. Slipetz
  • Patent number: 5759789
    Abstract: A novel prostaglandin receptor has been identified and DNA encoding the receptor has been isolated, purified, sequenced and expressed in host cells. This DNA encoding the novel prostaglandin receptor and host cells expressing the receptor are used to identify modulators of the prostaglandin receptor.
    Type: Grant
    Filed: August 5, 1996
    Date of Patent: June 2, 1998
    Assignee: Merck Frosst Canada, Inc.
    Inventors: Mark Abramovitz, Mohammed Adam, Lison Bastien, Richard Grygorczyk, Kathleen Metters, Thomas H. Ruchmore, Nicole Sawyer
  • Patent number: 5605814
    Abstract: A novel prostaglandin receptor has been identified and DNA encoding the receptor has been isolated, purified, sequenced and expressed in host cells. This DNA encoding the novel prostaglandin receptor and host cells expressing the receptor are used to identify modulators of the prostaglandin receptor.
    Type: Grant
    Filed: August 31, 1993
    Date of Patent: February 25, 1997
    Assignee: Merck Frosst Canada Inc.
    Inventors: Mark Abramovitz, Mohammed Adam, Lison Bastien, Richard Grygorczyk, Kathleen Metters, Thomas H. Rushmore, Nicole Sawyer